Thus, it is possible that ET-1 plays a potential role in ETD by an imbalance between endothelium-derived vasodilator and vasoconstrictor substances on the pathophysiology of vascular complications in diabetes [9]. The gene discussed is EDN1; the disease is diabetes mellitus.